Abstract
Detection of TG6002, nAb, 5-FC, 5-FU, and F-BAL in plasma following treatment. A, Plasma samples analyzed by qPCR to detect TG6002 following treatment. Values stated are the number of copies per milliliter (c/mL). B, Serum nAb titers (IC50) for n = 15 patients, sample availability–dependent. * P < 0.05, paired t test. C, Serum 5-FC, 5-FU, and F-BAL concentrations at day 8 following treatment (n = 13 patients), sample availability–dependent. Cohort 1: purple, cohort 2: green, cohort 3: blue, and cohort 4: red. BLD, below limit of detection; BLQ, below the limit of quantification; C, cycle; D, day; nAb, neutralizing antibody; ND, not done due to insufficient sample.